SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Advertising and generic market entry
16 references·0 citing·47 second hop
Advertising and generic market entry (2006)Advertising and generic market entryThe Pharmaceutical Industry (2013)The Pharmaceutical IndustryPharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals (2000)Pharmaceutical Policies in OE…Moral hazard in physician prescription behavior (2000)Moral hazard in physician pre…Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)Does Regulation Drive Out Com…Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Barriers to entry, brand adve…Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs (1999)Advertising and Competition i…The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…Pricing, Patent Loss and the Market for Pharmaceuticals (1992)Pricing, Patent Loss and the …Pricing, Patent Loss and the Market For Pharmaceuticals (1991)Pricing, Patent Loss and the …Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)Persuasion or Information? Pr…The Fat-Cat Effect, the Puppy-Dog Ploy, and the Lean and Hungry Look (1984)The Fat-Cat Effect, the Puppy…Advertising and Entry Deterrence: An Exploratory Model (1983)Advertising and Entry Deterre…Relaxing Price Competition Through Product Differentiation (1982)Relaxing Price Competition Th…Price competition, quality and income disparities (1979)Price competition, quality an…Advertising and Welfare (1978)Advertising and WelfareLimit Pricing and Entry under Incomplete Information: An Equilibrium Analysis (1982)Preemptive Patenting and the Persistence of Monopoly (1982)Multimarket Oligopoly: Strategic Substitutes and Complements (1985)First-mover advantages (1988)Quantity precommitment and Bertrand competition yield Cournot outcomes (1989)Chapter 31 Coordination and Lock-In: Competition with Switching Costs and Network Effects (2006)Stability in Competition (1929)On Hotelling's "Stability in Competition" (1979)Stability in Competition (1990)The economics of networks (1996)Econometric Measurement of the Duration of Advertising Effect on Sales (1976)Optimal Advertising and Optimal Quality (1976)Product differentiation advantages of pioneering brands (1980)Medical Innovation Revisited: Social Contagion versus Marketing Effort (2001)The economic analysis of advertising (2005)Chapter 28 The Economic Analysis of Advertising (2007)Barriers to New Competition (1957)Industrial Market Structure and Economic Performance. (1971)The Role of Investment in Entry-Deterrence (1980)Competition when Consumers have Switching Costs: An Overview with Applications to Industrial Organization, Macroeconomics, and International Trade (1995)Dynamic capabilities and strategic management (1997)Cost of innovation in the pharmaceutical industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries (2003)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)Economics of the Pharmaceutical Industry (2018)On the Pooling of Time Series and Cross Section Data (1978)Designing Economic Agents that Act Like Human Agents: A Behavioral Approach to Bounded Rationality (1991)Competition, Innovation and Productivity Growth: A Review of Theory and Evidence (2002)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)MONOPOLISTIC COMPETITION AND OPTIMUM PRODUCT DIVERSITY (1975)Reexamination of the perfectness concept for equilibrium points in extensive games (1975)Estimating Discrete-Choice Models of Product Differentiation (1994)Trade, Quality Upgrading and Wage Inequality in the Mexican Manufacturing Sector (2007)Entry, Capacity, Investment and Oligopolistic Pricing (1977)Entry and Competition in Concentrated Markets (1991)Technological and product‐market experience and the success of new product introductions in the pharmaceutical industry (2004)Evolution of R&D Capabilities: The Role of Knowledge Networks Within a Firm (2005)Free Entry and Social Inefficiency (1986)Estimation of a Model of Entry in the Airline Industry (1992)Automobile Prices in Market Equilibrium (1995)What do we know about entry? (1995)Generic Entry and the Pricing of Pharmaceuticals (1997)An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: impact of firm resources and capabilities (1999)Informative Advertising with Differentiated Products (1984)Sunk costs and market structure (1992)Pass-Through as an Economic Tool: Principles of Incidence under Imperfect Competition (2013)
this work references cited by second hop

References

  • 1982Relaxing Price Competition Through Product Differentiation1,960 cited
  • 1979Price competition, quality and income disparities1,071 cited
  • 1984The Fat-Cat Effect, the Puppy-Dog Ploy, and the Lean and Hungry Look873 cited
  • 1978Advertising and Welfare484 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 1988Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals254 cited
  • 2000Does Regulation Drive Out Competition in Pharmaceutical Markets?237 cited
  • 2000Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry226 cited
  • 1983Advertising and Entry Deterrence: An Exploratory Model198 cited
  • 2013The Pharmaceutical Industry196 cited
  • 1992Pricing, Patent Loss and the Market for Pharmaceuticals176 cited
  • 1999Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs176 cited
  • 2000Moral hazard in physician prescription behavior164 cited
  • 1991Pricing, Patent Loss and the Market For Pharmaceuticals

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

157 cited
  • 2000Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals135 cited
  • Cited by

    No citing works inside the corpus for this window.